Search

Your search keyword '"Favre, Claudio"' showing total 12 results
Start Over Author "Favre, Claudio" Publisher wiley
12 results on '"Favre, Claudio"'

1. Whole‐body magnetic resonance imaging for staging Langerhans cell histiocytosis in children and young adults

Author

Perrone, Anna, primary, Lakatos, Karoly, additional, Pegoraro, Francesco, additional, Trambusti, Irene, additional, Fotzi, Ilaria, additional, Selvi, Valeria, additional, Prosch, Helmut, additional, Sertorio, Fiammetta, additional, Pötschger, Ulrike, additional, Favre, Claudio, additional, Conte, Massimo, additional, Minkov, Milen, additional, and Sieni, Elena, additional

Published
2022
Full Text
View/download PDF

2. Phase 2 study for nonmetastatic extremity high‐grade osteosarcoma in pediatric and adolescent and young adult patients with a risk‐adapted strategy based on ABCB1/P‐glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS‐2)

Author

Palmerini, Emanuela, primary, Meazza, Cristina, additional, Tamburini, Angela, additional, Bisogno, Gianni, additional, Ferraresi, Virginia, additional, Asaftei, Sebastian D., additional, Milano, Giuseppe M., additional, Coccoli, Luca, additional, Manzitti, Carla, additional, Luksch, Roberto, additional, Serra, Massimo, additional, Gambarotti, Marco, additional, Donati, Davide M., additional, Scotlandi, Katia, additional, Bertulli, Rossella, additional, Favre, Claudio, additional, Longhi, Alessandra, additional, Abate, Massimo E., additional, Perrotta, Silverio, additional, Mascarin, Maurizio, additional, D’Angelo, Paolo, additional, Cesari, Marilena, additional, Staals, Eric L., additional, Marchesi, Emanuela, additional, Carretta, Elisa, additional, Ibrahim, Toni, additional, Casali, Paolo G., additional, Picci, Piero, additional, Fagioli, Franca, additional, and Ferrari, Stefano, additional

Published
2022
Full Text
View/download PDF

5. β 3 ‐Adrenoceptor as a potential immuno‐suppressor agent in melanoma

Author

Calvani, Maura, primary, Bruno, Gennaro, additional, Dal Monte, Massimo, additional, Nassini, Romina, additional, Fontani, Filippo, additional, Casini, Arianna, additional, Cavallini, Lorenzo, additional, Becatti, Matteo, additional, Bianchini, Francesca, additional, De Logu, Francesco, additional, Forni, Giulia, additional, Marca, Giancarlo, additional, Calorini, Lido, additional, Bagnoli, Paola, additional, Chiarugi, Paola, additional, Pupi, Alberto, additional, Azzari, Chiara, additional, Geppetti, Pierangelo, additional, Favre, Claudio, additional, and Filippi, Luca, additional

Published
2019
Full Text
View/download PDF

10. Long-term results of the first Italian Association of Pediatric Hematology and Oncology protocol for the treatment of pediatric B-cell non-Hodgkin lymphoma (AIEOP LNH92)

Author

Pillon, Marta, primary, Di Tullio, Maria Teresa, additional, Garaventa, Alberto, additional, Cesaro, Simone, additional, Putti, Maria Caterina, additional, Favre, Claudio, additional, Lippi, Alma, additional, Surico, Gianmarco, additional, Di Cataldo, Andrea, additional, D'Amore, Emanuele, additional, Zanesco, Luigi, additional, and Rosolen, Angelo, additional

Published
2004
Full Text
View/download PDF

11. Mobilization, collection, and characterization of peripheral blood hemopoietic progenitors after chemotherapy with epirubicin, paclitaxel, and granulocyte-colony stimulating factor administered to patients with metastatic breast carcinoma

Author

Bengala, Carmelo, primary, Pazzagli, Ilaria, additional, Tibaldi, Carmelo, additional, Favre, Claudio, additional, Vanacore, Renato, additional, Greco, Francesco, additional, Mazzoni, Alessandro, additional, Menconi, Maria Cristina, additional, Macchia, Pierantonio, additional, and Conte, Pier Franco, additional

Published
1998
Full Text
View/download PDF

12. β-Adrenoceptors as drug targets in melanoma: novel preclinical evidence for a role of β 3 -adrenoceptors.

Author

Dal Monte M, Calvani M, Cammalleri M, Favre C, Filippi L, and Bagnoli P

Subjects
Animals, Cell Proliferation drug effects, Cell Survival drug effects, Humans, Melanoma metabolism, Melanoma pathology, Skin Neoplasms metabolism, Skin Neoplasms pathology, Adrenergic beta-Antagonists pharmacology, Melanoma drug therapy, Receptors, Adrenergic, beta-3 metabolism, Skin Neoplasms drug therapy
Abstract

Stress plays a role in tumourigenesis through catecholamines acting at β-adrenoceptors including β 1 -, β 2 - and β 3 -adrenoceptors, and the use of β-adrenoceptor antagonists seems to counteract tumour growth and progression. Preclinical evidence and meta-analysis data demonstrate that melanoma shows a positive response to β-adrenoceptor blockers and in particular to propranolol acting mainly at β 1 - and β 2 -adrenoceptors. Although evidence suggesting that β 3 -adrenoceptors may play a role as a therapeutic target in infantile haemangiomas has been recently reviewed, a comprehensive analysis of the data available from preclinical studies supporting a possible role of β 3 -adrenoceptors in melanoma was not available. Here, we review data from the literature demonstrating that propranolol may be effective at counteracting melanoma growth, and we provide preclinical evidence that β 3 -adrenoceptors may also play a role in the pathophysiology of melanoma, thus opening the door for further clinical assays trying to explore β 3 -adrenoceptor blockers as novel alternatives for its treatment. LINKED ARTICLES: This article is part of a themed section on Adrenoceptors-New Roles for Old Players. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.14/issuetoc., (© 2018 The British Pharmacological Society.)

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results